These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 18578558

  • 1. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.
    Tredger JM, Brown NW, Dhawan A.
    Drugs; 2008; 68(10):1385-414. PubMed ID: 18578558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM, Kobashigawa J, Klintmalm G.
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [Abstract] [Full Text] [Related]

  • 4. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B, Tönshoff B.
    Paediatr Drugs; 2011 Feb 01; 13(1):49-69. PubMed ID: 21162600
    [Abstract] [Full Text] [Related]

  • 5. Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy.
    Tsai MK, Wu FL, Lai IR, Lee CY, Hu RH, Lee PH.
    Int J Artif Organs; 2009 Jun 01; 32(6):371-80. PubMed ID: 19670189
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.
    Health Technol Assess; 2005 May 01; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients.
    Baczkowska T, Durlik M.
    Pol Arch Med Wewn; 2009 May 01; 119(5):318-25. PubMed ID: 19579814
    [Abstract] [Full Text] [Related]

  • 9. Belatacept for kidney transplant recipients.
    Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.
    Cochrane Database Syst Rev; 2014 Nov 24; 2014(11):CD010699. PubMed ID: 25416857
    [Abstract] [Full Text] [Related]

  • 10. Optimizing the immunosuppressive regimen in heart transplantation.
    Eisen H, Ross H.
    J Heart Lung Transplant; 2004 May 24; 23(5 Suppl):S207-13. PubMed ID: 15093807
    [Abstract] [Full Text] [Related]

  • 11. Minimizing calcineurin inhibitor drugs in renal transplantation.
    Flechner SM.
    Transplant Proc; 2003 May 24; 35(3 Suppl):118S-121S. PubMed ID: 12742481
    [Abstract] [Full Text] [Related]

  • 12. Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview.
    Höcker B, Tönshoff B.
    Paediatr Drugs; 2009 May 24; 11(6):381-96. PubMed ID: 19877724
    [Abstract] [Full Text] [Related]

  • 13. The safety of calcineurin inhibitors for kidney-transplant patients.
    Malvezzi P, Rostaing L.
    Expert Opin Drug Saf; 2015 Oct 24; 14(10):1531-46. PubMed ID: 26329325
    [Abstract] [Full Text] [Related]

  • 14. Calcineurin inhibitor sparing in renal transplantation.
    Ekberg H.
    Transplantation; 2008 Sep 27; 86(6):761-7. PubMed ID: 18813097
    [Abstract] [Full Text] [Related]

  • 15. Calcineurin inhibitor-free protocols: risks and benefits.
    Barbari AG, Stephan AG, Masri MA.
    Saudi J Kidney Dis Transpl; 2007 Mar 27; 18(1):1-23. PubMed ID: 17237886
    [Abstract] [Full Text] [Related]

  • 16. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 17. High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study.
    Burkhalter F, Oettl T, Descoeudres B, Bachmann A, Guerke L, Mihatsch MJ, Dickenmann M, Steiger J.
    Transplant Proc; 2012 Dec 27; 44(10):2961-5. PubMed ID: 23195006
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitor minimization in pediatric liver allograft recipients.
    Dell-Olio D, Kelly DA.
    Pediatr Transplant; 2009 Sep 27; 13(6):670-81. PubMed ID: 19413716
    [Abstract] [Full Text] [Related]

  • 19. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K.
    Drugs; 2003 Sep 27; 63(15):1535-48. PubMed ID: 12887261
    [Abstract] [Full Text] [Related]

  • 20. Calcineurin inhibitor avoidance and withdrawal for kidney transplantation: a systematic review and meta-analysis of randomized controlled trials.
    Yan HL, Zong HT, Cui YS, Li N, Zhang Y.
    Transplant Proc; 2014 Jun 27; 46(5):1302-13. PubMed ID: 24935293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.